Prevalence of serum anti M-type phospholipase A2 receptor antibody in primary membranous nephropathy: A single center experience
Authors:
Open Access
- 1 January 2016
- journal article
- research article
- Published by Scientific Scholar in Indian Journal of Nephrology
- Vol. 26 (4) , 257-61
Abstract
We conducted a prospective study to assess utility of detection of antibodies to phospholipase A2receptor (PLA2R) in the serum of patients with membranous nephropathy. Seventy five patients with biopsy proven membranous nephropathy admitted between January 2011 and September 2014 were studied. Serum anti- PLA2R was tested by indirect immunofluorescence. The test was positive in 45 out of 60 patients with primary membranous nephropathy (PMN) and in none of the 15 patients with secondary membranous nephropathy, with a sensitivity of 75% and specificity of 100% for PMN. Anti PLA2R positivity also showed a significant correlation with quantum of proteinuria and negative correlation with serum albumin.This study has validated detection of serum anti PLA2R in PMN as a non invasive diagnostic tool in Indian patients.Keywords
This publication has 14 references indexed in Scilit:
- Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2014
- Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathyKidney International, 2013
- Autoantibodies against Phospholipase A2 Receptor in Korean Patients with Membranous NephropathyPLOS ONE, 2013
- Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2011
- Anti-Phospholipase A2 Receptor Antibody in Membranous NephropathyJournal of the American Society of Nephrology, 2011
- An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritisNephrology Dialysis Transplantation, 2011
- Antigen Identification in Membranous Nephropathy Moves toward Targeted Monitoring and New TherapyJournal of the American Society of Nephrology, 2010
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous NephropathyJournal of the American Society of Nephrology, 2007
- Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy11See Editorial by Cattran, p. 349.Kidney International, 2002